Gilead Sued In Calif. Over Remdesivir COVID-19 Claims
Patients hospitalized with COVID-19 and their surviving families are suing pharmaceutical company Gilead Sciences Inc. over the antiviral drug remdesivir, alleging the drug that received emergency approval in May 2020 was...To view the full article, register now.
Already a subscriber? Click here to view full article